Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

Walter Reed National Military Medical Center · NCT06275373

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
100
US sites recruiting
1
Study start
May 12, 2021
Record last updated
February 23, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam lid/orbital edema, or lid/orbital erythema recommended for treatment with teprotumumab infusion (Tepezza®). Patients recommended for treatment will be evaluated by an oculoplastic surgeon (Dr. Eva Chou) and endocrinologist (Dr. Thanh Hoang).

Being studied: Teprotumumab Injection [Tepezza]

Conditions: Thyroid Eye Disease; Graves Ophthalmopathy; Graves Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • only DOD beneficiaries
  • adult patients 18 years of age or older
  • adult patients with proptosis, ocular/orbital pain, diplopia, lid/orbital edema, or lid/orbital erythema associated with autoimmune thyroid disease

Exclusion Criteria

  • Patients with evidence of compressive optic neuropathy necessitating urgent orbital decompression or external beam radiation
  • patients with a history of uncontrolled diabetes mellitus
  • patients with a history/diagnosis of uncontrolled inflammatory bowel disease
  • patients under age 18 years
  • patients who are pregnant or trying to become pregnant.

Recruiting US locations

  • Walter Reed National Military Medical Center

    Bethesda, MD 20889

    Site contact: Thanh D Hoang, DO · 301-295-5165 · thanh.d.hoang.mil@health.mil

Study contacts (from the official record)

  • THANH D HOANG, DO · 3012955165 · thanh.d.hoang.mil@health.mil
  • Iris Morris, PhD · 3013194599 · iris.e.morris3.civ@health.mil
All healthy volunteers studies in Maryland →
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid… (NCT06275373) | Bored Studies